Menaquinone-4 is a menaquinone whose side-chain contains 4 isoprene units in an all-trans-configuration. Among its listed roles, it functions as a bone density conservation agent, a human metabolite, an antioxidant, an anti-inflammatory agent and a neuroprotective agent. Menatetrenone has been used in trials studying the treatment of Diabetes, Osteoporosis, Prediabetic State, and Hepatocellular Carcinoma. It is grouped under the following drug class(es): Vitamins. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Menaquinone-4 and Kaytwo. Its PubChem CID is 5282367.
Menatetrenone
| CAS No | 863-61-6 |
|---|---|
| Molecular Formula | C31H40O2 |
| Molecular Weight | 444.60 g/mol |
| Synonyms | 2-methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]naphthalene-1,4-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Menaquinone-4 is a menaquinone whose side-chain contains 4 isoprene units in an all-trans-configuration. Among its listed roles, it functions as a bone density conservation agent, a human metabolite, an antioxidant, an anti-inflammatory agent and a neuroprotective agent.
The listed CAS number is 863-61-6.
The listed molecular formula is C31H40O2.
The listed molecular weight is 444.60 g/mol.
2-methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]naphthalene-1,4-dione.
The source lists Menaquinone-4 and Kaytwo.